Express Scripts Further Advances Transparency and Affordability for Consumers and Clients
Express Scripts, the pharmacy benefits management business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today announced several actions to further evolve its pharmacy benefit management (...
Read MoreClinically Speaking: Boosting Biosimilars Competition and Savings
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Read MoreDrug Lists 101 – Supporting Access to Safe and Effective Medications
Drug formularies are critical to combat the estimated $16 billion wasted each year on low value drugs that do not improve health outcomes.
Read MoreStrategies to Encourage the Adoption of Biosimilars
Here are three ways plan sponsors can promote and manage the appropriate use of biosimilars to improve drug affordability and access for members.
Read MoreHere’s what drug makers don’t want you to know about PBMs
Pharmacy benefit managers shield patients from higher drug prices, but drug makers don’t want you to know that.
Read MoreExpress Scripts Introduces New Option to Give Clients Maximum Simplicity in Drug Pricing
Express Scripts ClearNetwork offers employers and health plans a new option for simple, “cost-plus” pharmacy pricing for brand, generic, and specialty medications.
Read MoreMaintaining High-Quality, Affordable Employer-Based Medicare Coverage
Employer Group Waiver Plans provide flexibilities that allow customized coverage to support each employer’s retiree benefit commitments.
Read More